Last $0.57 USD
Change Today -0.001 / -0.17%
Volume 58.5K
ANTH On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 1:15 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

anthera pharmaceuticals inc (ANTH) Snapshot

Open
$0.57
Previous Close
$0.58
Day High
$0.58
Day Low
$0.56
52 Week High
06/26/12 - $3.21
52 Week Low
02/25/13 - $0.49
Market Cap
87.8M
Average Volume 10 Days
1.1M
EPS TTM
$-0.77
Shares Outstanding
152.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ANTHERA PHARMACEUTICALS INC (ANTH)

Related News

No related news articles were found.

anthera pharmaceuticals inc (ANTH) Related Businessweek News

No Related Businessweek News Found

anthera pharmaceuticals inc (ANTH) Details

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing products to treat diseases associated with inflammation and autoimmune diseases. The company’s primary product candidate is blisibimod, which is in Phase III clinical trials targeting elevated levels of B-cell activating factor (BAFF) associated with various B-cell mediated autoimmune diseases, including systemic lupus erythematosus, IgA nephropathy, lupus nephritis, vasculitis, rheumatoid arthritis, idiopathic thrombocytopenia purpura, and others. It has a license agreement with Amgen Inc. to develop and commercialize BAFF inhibitor blisibimod, as well as non-exclusive rights to certain technology relating to peptibody compositions and formulations. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.

23 Employees
Last Reported Date: 03/26/13
Founded in 2004

anthera pharmaceuticals inc (ANTH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $507.9K
Chief Financial Officer and Chief Business Of...
Total Annual Compensation: $347.5K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $347.5K
Chief Technology Officer and Senior Vice Pres...
Total Annual Compensation: $327.7K
Compensation as of Fiscal Year 2012.

anthera pharmaceuticals inc (ANTH) Key Developments

Anthera Pharmaceuticals, Inc. Announces Executive Changes

Anthera Pharmaceuticals, Inc. announced the appointment of May Liu as its Senior Vice President, Finance and Administration. In this position, Ms. Liu will oversee the finance, investor relations and general administration functions of Anthera in addition to her role as Principal Accounting Officer. Ms. Liu has served as the company's Vice President, Finance since January 2011. Prior to that, she served as Anthera's Corporate Controller since October 2007. Ms. Liu joined the Company as Director of Finance in April 2007. Effective June 30, 2013 Anthera's Chief Business Officer and Chief Financial Officer, Christopher Lowe will leave the company to pursue entrepreneurial opportunities.

Anthera Pharmaceuticals, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-06-2013 01:30 PM

Anthera Pharmaceuticals, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-06-2013 01:30 PM. Venue: Grand Hyatt Hotel, 109 East 42nd Street at Grand Central, New York, New York, United States. Speakers: Colin Hislop, Chief Medical Officer and Senior Vice President, Paul F. Truex, Chief Executive Officer, President and Director.

Anthera Pharmaceuticals, Inc. Announces Management Changes

Anthera Pharmaceuticals, Inc. announced that Peter Thompson, M.D., a director of the company, resigned from the board of directors of the company effective upon the company's 2013 annual meeting of stockholders. May Liu, 37, was appointed as principal accounting officer. Ms. Liu has served as the company's vice president, finance since January 2011. Prior to that, she served as Anthera's Corporate Controller since October 2007. Ms. Liu joined the company as Director of Finance in April 2007. Prior to that, Ms. Liu served as SEC Reporting and Technical Accounting Manager at Renovis, Inc., from October 2005 to March 2007.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANTH:US $0.57 USD -0.001

ANTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANTH.
View Industry Companies
 

Industry Analysis

ANTH

Industry Average

Valuation ANTH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTHERA PHARMACEUTICALS INC, please visit www.anthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.